DANIEL G WELCH Insider Trading Transactions
Get free email notifications about insider trading for DANIEL G WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is CEO and President in INTERMUNE INC ($ITMN) and Chairman, CEO and President in INTERMUNE INC ($ITMN) and President & CEO in INTERMUNE INC ($ITMN) and President and CEO in INTERMUNE INC ($ITMN) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in HYPERION THERAPEUTICS INC ($HPTX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in AveXis, Inc. ($AVXS) and Director in Nuvation Bio Inc. ($PANA).
Latest Insider Trading Transactions of DANIEL G WELCH
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12 2021 | PANA | Nuvation Bio Inc. | WELCH DANIEL G | Director | Option Exercise | A | 1.74 | 312,750 | 544,185 | 312,750 | |
Feb 12 2021 | PANA | Nuvation Bio Inc. | WELCH DANIEL G | Director | Option Exercise | A | 4.60 | 86,184 | 396,446 | 86,184 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 9,518 | 190,931 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 7,982 | 160,119 | 9,518 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 19.02 | 14,500 | 275,790 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 164.61 | 9,250 | 1,522,643 | 47,348 | 56.6 K to 47.3 K (-16.34 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.06 | 14,500 | 2,393,370 | 56,598 | 71.1 K to 56.6 K (-20.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 19.02 | 14,500 | 275,790 | 71,098 | 56.6 K to 71.1 K (+25.62 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.72 | 9,518 | 1,577,323 | 56,598 | 66.1 K to 56.6 K (-14.40 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 9,518 | 190,931 | 66,116 | 56.6 K to 66.1 K (+16.82 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 166.70 | 7,982 | 1,330,599 | 56,598 | 64.6 K to 56.6 K (-12.36 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 7,982 | 160,119 | 64,580 | 56.6 K to 64.6 K (+14.10 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 167.34 | 8,750 | 1,464,225 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 36.70 | 8,750 | 321,125 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 168.24 | 8,750 | 1,472,100 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 34.25 | 8,750 | 299,688 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,550 | 0 | 12,300 | 9.8 K to 12.3 K (+26.15 %) |
Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,595 | 0 | 8,060 | 6.5 K to 8.1 K (+24.67 %) |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,335 | 0 | 56,598 | 55.3 K to 56.6 K (+2.42 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.77 | 205 | 34,188 | 55,263 | 55.5 K to 55.3 K (-0.37 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.23 | 2,435 | 404,770 | 55,468 | 57.9 K to 55.5 K (-4.21 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 164.98 | 4,319 | 712,549 | 57,903 | 62.2 K to 57.9 K (-6.94 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 164.21 | 8,041 | 1,320,413 | 62,222 | 70.3 K to 62.2 K (-11.44 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 167.99 | 284 | 47,709 | 70,263 | 70.5 K to 70.3 K (-0.40 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 167.26 | 11,011 | 1,841,700 | 70,547 | 81.6 K to 70.5 K (-13.50 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.27 | 5,400 | 897,858 | 81,558 | 87 K to 81.6 K (-6.21 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 165.62 | 3,305 | 547,374 | 86,958 | 90.3 K to 87 K (-3.66 %) |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 12.76 | 17,500 | 223,300 | 90,263 | 72.8 K to 90.3 K (+24.05 %) |
Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,570 | 0 | 6,465 | 4.9 K to 6.5 K (+32.07 %) |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,787 | 0 | 4,895 | 3.1 K to 4.9 K (+57.50 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 69,800 | 66.1 K to 69.8 K (+5.60 %) |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 20.00 | 35,552 | 711,040 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Buy | D | 0.00 | 1,106 | 0 | 0 | -1,106 to 0 (-100.00 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 8.38 | 6,881 | 57,663 | 0 | |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 8.38 | 6,881 | 57,663 | 66,100 | 59.2 K to 66.1 K (+11.62 %) |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 10.08 | 10,000 | 100,800 | 59,219 | 49.2 K to 59.2 K (+20.32 %) |
Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Sell | S | 123.93 | 602 | 74,604 | 3,108 | 3.7 K to 3.1 K (-16.23 %) |
Jul 21 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Sell | S | 126.76 | 217 | 27,507 | 3,710 | 3.9 K to 3.7 K (-5.53 %) |
Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,423 | 0 | 3,927 | 2.5 K to 3.9 K (+56.83 %) |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
Jun 01 2017 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 49,219 | 45.5 K to 49.2 K (+8.13 %) |
Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
May 24 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
May 24 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 45,519 | 41.8 K to 45.5 K (+8.85 %) |
Mar 10 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 9.82 | 25,000 | 245,500 | 0 | |
Mar 10 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 9.82 | 25,000 | 245,500 | 41,819 | 16.8 K to 41.8 K (+148.64 %) |
Feb 12 2016 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 20.00 | 8,385 | 167,700 | 8,385 | |
Feb 12 2016 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 20.00 | 27,167 | 543,340 | 27,167 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 183.62 | 3,500 | 642,670 | 3,500 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K |
Jun 22 2015 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Option Exercise | A | 97.85 | 7,500 | 733,875 | 7,500 | ||
May 19 2015 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
May 19 2015 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 16,819 | 13.1 K to 16.8 K (+28.20 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | WELCH DANIEL G | Director | Option Exercise | D | 26.97 | 4,869 | 131,317 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | WELCH DANIEL G | Director | Option Exercise | D | 24.46 | 9,800 | 239,708 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | WELCH DANIEL G | Director | Option Exercise | D | 10.32 | 20,000 | 206,400 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | WELCH DANIEL G | Director | Sell | D | 46.00 | 2,617 | 120,382 | 0 | 2.6 K to 0 (-100.00 %) |
Apr 10 2015 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 59.95 | 17,500 | 1,049,125 | 17,500 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 15.34 | 6,518 | 99,986 | 158,538 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 15.34 | 1 | 15 | 152,020 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 8.73 | 25,000 | 218,250 | 152,019 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 25.55 | 3,913 | 99,977 | 127,019 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 8.73 | 25,000 | 218,250 | 123,106 | |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 36.01 | 31,519 | 1,135,012 | 98,106 | 129.6 K to 98.1 K (-24.32 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 15.34 | 6,518 | 99,986 | 129,625 | 123.1 K to 129.6 K (+5.29 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 15.34 | 1 | 15 | 123,107 | 123.1 K to 123.1 K (0.00 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 8.73 | 25,000 | 218,250 | 123,106 | 98.1 K to 123.1 K (+25.48 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 33.39 | 28,913 | 965,370 | 98,106 | 127 K to 98.1 K (-22.76 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 25.55 | 3,913 | 99,977 | 127,019 | 123.1 K to 127 K (+3.18 %) |
May 07 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 8.73 | 25,000 | 218,250 | 123,106 | 98.1 K to 123.1 K (+25.48 %) |
Apr 03 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 33.57 | 3,673 | 123,287 | 98,106 | 101.8 K to 98.1 K (-3.61 %) |
Mar 05 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 31.52 | 15,655 | 493,483 | 121,779 | 137.4 K to 121.8 K (-11.39 %) |
Feb 27 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 25.55 | 41,087 | 1,049,773 | 0 | |
Feb 27 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 32.63 | 41,087 | 1,340,767 | 137,434 | 178.5 K to 137.4 K (-23.02 %) |
Feb 27 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 25.55 | 41,087 | 1,049,773 | 178,521 | 137.4 K to 178.5 K (+29.90 %) |
Feb 05 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 13.08 | 20,000 | 261,600 | 117,434 | 137.4 K to 117.4 K (-14.55 %) |
Jan 21 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 18.02 | 50,000 | 901,085 | 37,434 | 87.4 K to 37.4 K (-57.19 %) |
Jan 14 2014 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 17.00 | 50,000 | 850,040 | 87,434 | 137.4 K to 87.4 K (-36.38 %) |
Dec 04 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 13.99 | 20,000 | 279,800 | 137,434 | 157.4 K to 137.4 K (-12.70 %) |
Oct 03 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 8.73 | 50,000 | 436,500 | 324,999 | |
Oct 03 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 15.43 | 70,000 | 1,080,016 | 157,434 | 227.4 K to 157.4 K (-30.78 %) |
Oct 03 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 8.73 | 50,000 | 436,500 | 227,434 | 177.4 K to 227.4 K (+28.18 %) |
Jun 03 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | A | 9.99 | 165,000 | 1,648,350 | 165,000 | |
Jun 03 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Jun 05 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 9.89 | 2,819 | 27,889 | 177,434 | 180.3 K to 177.4 K (-1.56 %) |
May 13 2013 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 9.27 | 3,007 | 27,863 | 180,253 | 183.3 K to 180.3 K (-1.64 %) |
Jun 11 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 10.02 | 23,341 | 233,877 | 183,260 | 206.6 K to 183.3 K (-11.30 %) |
Jun 06 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | A | 10.10 | 150,000 | 1,515,000 | 150,000 | |
Jun 06 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Grant | A | 10.10 | 30,000 | 303,000 | 206,601 | 176.6 K to 206.6 K (+16.99 %) |
Jun 06 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Grant | A | 10.10 | 30,000 | 303,000 | 176,601 | 146.6 K to 176.6 K (+20.46 %) |
May 14 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 11.75 | 2,064 | 24,248 | 212,601 | 214.7 K to 212.6 K (-0.96 %) |
May 14 2012 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 11.54 | 2,935 | 33,862 | 214,665 | 217.6 K to 214.7 K (-1.35 %) |
Dec 09 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 17.39 | 23,340 | 405,897 | 217,600 | 240.9 K to 217.6 K (-9.69 %) |
Jun 09 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 33.54 | 18,340 | 615,197 | 240,940 | 259.3 K to 240.9 K (-7.07 %) |
May 18 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 37.22 | 20,750 | 772,323 | 259,280 | 280 K to 259.3 K (-7.41 %) |
May 18 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 38.22 | 3,505 | 133,961 | 280,030 | 283.5 K to 280 K (-1.24 %) |
May 18 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 38.00 | 1,608 | 61,104 | 283,535 | 285.1 K to 283.5 K (-0.56 %) |
May 17 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 38.38 | 2,108 | 80,908 | 285,447 | 287.6 K to 285.4 K (-0.73 %) |
May 12 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | A | 39.46 | 80,000 | 3,156,800 | 80,000 | |
May 12 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Grant | A | 0.00 | 32,000 | 0 | 287,555 | 255.6 K to 287.6 K (+12.52 %) |
Mar 24 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 43.52 | 17,440 | 758,973 | 255,555 | 273 K to 255.6 K (-6.39 %) |
Mar 04 2011 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 39.69 | 44,000 | 1,746,263 | 272,995 | 317 K to 273 K (-13.88 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 20.08 | 50,000 | 1,004,000 | 0 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 20.08 | 50,000 | 1,004,000 | 0 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 15.34 | 39,374 | 603,997 | 21,607 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 15.40 | 83,507 | 1,286,008 | 0 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 12.74 | 137,151 | 1,747,304 | 0 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | M | 10.11 | 140,109 | 1,416,502 | 0 | |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Sell | S | 29.15 | 507,663 | 14,797,310 | 316,995 | 824.7 K to 317 K (-61.56 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 20.08 | 50,000 | 1,004,000 | 824,658 | 774.7 K to 824.7 K (+6.45 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 20.08 | 50,000 | 1,004,000 | 774,658 | 724.7 K to 774.7 K (+6.90 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 15.34 | 39,374 | 603,997 | 724,658 | 685.3 K to 724.7 K (+5.75 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 15.40 | 83,507 | 1,286,008 | 685,284 | 601.8 K to 685.3 K (+13.88 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 12.74 | 137,151 | 1,747,304 | 601,777 | 464.6 K to 601.8 K (+29.52 %) |
Dec 21 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Buy | M | 10.11 | 140,109 | 1,416,502 | 464,626 | 324.5 K to 464.6 K (+43.17 %) |
Jun 10 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Option Exercise | A | 8.73 | 375,000 | 3,273,750 | 375,000 | |
Jun 10 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Grant | A | 0.00 | 150,000 | 0 | 324,517 | 174.5 K to 324.5 K (+85.95 %) |
May 17 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 10.26 | 11,624 | 119,296 | 174,517 | 186.1 K to 174.5 K (-6.24 %) |
May 17 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 10.26 | 1,376 | 14,122 | 186,141 | 187.5 K to 186.1 K (-0.73 %) |
May 17 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | Chairman, CEO and P ... | Payment of Exercise | F | 10.57 | 2,120 | 22,415 | 187,517 | 189.6 K to 187.5 K (-1.12 %) |
Mar 23 2010 | ITMN | INTERMUNE INC | WELCH DANIEL G | CEO and President | Option Exercise | M | 12.74 | 7,849 | 99,996 | 0 |